PostDose.

Guides

Medical Weight Loss in Houston: How to Tell a Legitimate Clinic

"Medical weight loss" is a marketing phrase, not a credential. Four checks — prescriber, medication sourcing, disqualifying programs, physical practice — that separate a legitimate Houston clinic from the rest, with the FDA rules behind each one.

Search “medical weight loss clinic” in Houston and you’ll get hundreds of results: hormone clinics, med spas, primary care practices, IV bars, and storefronts that opened last quarter. The phrase “medically supervised” appears on nearly all of them. It is a marketing phrase, not a credential — no license, registry, or accreditation attaches to it, and nothing stops a business with no physician on site from using it.

Four checks do most of the work of telling them apart. They’re the same four we run on every clinic in this directory, and you can run all of them yourself before you book.

1. Can you name the prescriber — and find them?

GLP-1 medications, phentermine, and every other prescription weight-loss drug require a licensed prescriber. So the first question is who, specifically, is writing your prescription: a physician, nurse practitioner, or physician assistant with a name and a credential.

“Our medical team” is not an answer. Neither is a first name. When a clinic names its prescriber, you can verify them in about thirty seconds in the NPI Registry, the federal government’s free, public lookup of every provider with a National Provider Identifier. Search the name, filter to Texas, and confirm the credential matches what the clinic claims. Every clinic we mark verified has cleared this step; a name that returns nothing in Texas is where our verification stops.

2. What drug, exactly?

This is where most Houston clinics quietly fail. A weight-loss page that says “GLP-1 therapy” or “semaglutide program” without naming the product is leaving out the thing that determines whether the program is legal.

The FDA’s compounding shortage exemption for semaglutide and tirzepatide is over. In its April 1, 2026 policy clarification, the agency confirmed that a compounded version of a commercially available drug is generally treated as “essentially a copy,” which section 503A restricts absent a documented, patient-specific medical need. The FDA also closed the obvious workaround: combining semaglutide with another ingredient — vitamin B12 is the agency’s own example — still counts as essentially a copy when the dose is within 10% of the approved strength and given by the same route. A “semaglutide blend” is not a different drug.

So ask plainly: is this Wegovy, Ozempic, Zepbound, or Mounjaro, or is it compounded? If compounded, what is the documented medical reason? A legitimate clinic answers in writing. We cover the full rule in our guide on brand vs. compounded GLP-1s.

3. Does the program include something disqualifying?

Some offerings end the conversation regardless of how good the rest of the clinic looks.

The HCG diet. There are no FDA-approved HCG products for weight loss — the approved uses are select cases of female infertility and hormone treatment in men. The FDA states that HCG has not been demonstrated to be effective in treating obesity and that there is no substantial evidence it increases weight loss. Every product marketed as “homeopathic” HCG is, in the agency’s words, illegally marketed. The HCG protocol also requires a very low calorie diet, which carries documented risk of gallstone formation, electrolyte imbalance, and heart arrhythmias.

Research-only peptides sold for human use. BPC-157, CJC-1295, ipamorelin, tesamorelin blends, and similar compounds are commonly sold as “wellness” or “recovery” therapy while carrying no FDA approval for any human indication. Clinics sometimes disclose this in the fine print of the same page that sells the injection.

Medication without a real consult. A program that ships a prescription drug after a form and a credit card, with no examination and no follow-up, is not medical supervision.

4. Is there a real practice behind it?

A physical Houston-area address, a prescriber who practices there, and a review history with enough volume to mean something. Telehealth is legitimate care, but a website with no clinical practice behind it is not a local weight-loss clinic, whatever its ad targeting says.

What this filters out in practice

In our initial Houston sweep we evaluated 80 clinics and excluded 41 outright — most often for compounded GLP-1s marketed as the core product with no sourcing disclosure, or peptide menus built on research-only compounds. Continuous re-verification since launch has removed four more, and the pattern in those four is the useful part.

One had a named, NPI-verified prescriber and named brand GLP-1s on its site — and also ran an HCG diet program, which disqualified it on its own. Another had been listed as verified until a routine recheck found compounded semaglutide named as the core of its weight-loss offering; the prescriber was real and active in the registry, but that doesn’t offset the offering. Passing three checks is not passing.

That’s the honest version of what a directory can and can’t tell you. We publish what we verify and how, and you can browse the clinics that currently clear all four in Houston.


Sources: U.S. Food and Drug Administration, “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize”, content current as of April 1, 2026. FDA, “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss”, content current as of September 1, 2026. FDA, “Questions and Answers on HCG Products for Weight Loss”, last updated May 4, 2016. Centers for Medicare & Medicaid Services, NPI Registry, queried September 4, 2026.

This article is independent editorial content, not medical advice. See our medical disclaimer.